Sustained Therapeutics is a clinical-stage company utilizing its advanced clinical and research expertise to develop non-opioid locally injected sustained-release therapeutics primarily for the treatment of pain. A spin-off from the University of British Columbia and the Vancouver Prostate Centre, their novel sustained-release drug delivery platform has the potential to provide effective, long-lasting solutions for managing both acute and chronic pain. The company also plans to develop the platform to enable sustained release treatments for cancer and inflammatory diseases.
Company Details
- Employees
- 5
- Address
- Vancouver, Bc V6h 3z6, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Vancouver, BC
Sustained Therapeutics Questions
Sustained Therapeutics's website is https://sustainedtherapeutics.com/
Sustained Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/sustained-therapeutics
Sustained Therapeutics has
5 employees.
View email and phone details for 5
employees at Sustained Therapeutics.
Sustained Therapeutics's industry is
Biotechnology Research
Sustained Therapeutics's top competitors are
Voxcell Bioinnovation,
Seragene Therapeutics,
Entos Pharmaceuticals,
Integrated Nanotherapeutics Inc.,
Total Flow Medical,
Microbion Corporation,
Qu Biologics Inc.,
Htuo Biosciences,
Zymeworks Inc.,
Bold Therapeutics Inc..
Sustained Therapeutics's categories are Biotechnology Research
